Font Size: a A A
Keyword [Neoadjuvant chemoradiotherapy]
Result: 41 - 60 | Page: 3 of 10
41. Effect Of Neoadjuvant Chemoradiotherapy In Locally Advanced Mid Rectal Cancer On Short-and-long-term Efficacy
42. Prognostic Significance Of Lymph Node Status And Lymph Node Ratio In Rectal Cancer After Neoadjuvant Chemoradiotherapy
43. A Comparative Study On Diagnostic Value Of MSCT And Mri In Preoperative Local Staging For Rectal Cancer After Neoadjuvant Chemoradiotherapy
44. Effects Of Preoperative Enteral Nutrition On Postoperative Recent Nutritional Status In Patients With Siewert Ⅱ And Ⅲ Adenocarcinoma Of Esophagogastric Junction After Neoadjuvant Chemoradiotherapy
45. To Detect The Relationship Between Expression Of Stat3 As Well As Survivin In Rectal Cancer Tissue And Effect Of Neoadjuvant Chemoradiotherapy
46. Clinical Efficacy Of Neoadjuvant Chemoradiotherapy In Middle And Low Rectal Cancer With CⅡ-cⅢ Stage And The Effect Of NCRT On The Expression Of VEGF In Rectal Cancer
47. Clinical Significance Of Tumor‐associated Neutrophils Infiltration Peri-neoadjuvant Chemoradiotherapy In Rectal Cancer
48. Short-term Efficacy And Related Factors Of Neoadjuvant Chemoradiotherapy And Postoperative Adjuvant Chemoradiotherapy For Locally Advanced Rectal Cancer
49. The Effect And Clinical Significance Analysis Of Local Advanced Rectal Cancer To Neoadjuvant Chemoradiotherapy Combined With Laparoscopic TME Surgery
50. The Value Of Dynamic Contrast-enhanced Magnetic Resonance Imaging In The Evaluation Of Neoadjuvant Chemoradiotherapy For Rectal Cancer
51. Detecting The Hight Risk Of Regional Lymph Node Metastasis After Neoadjuvant Chemoradiotherapy For Local Advanced Rectal Cancer And A Scoring System To Predict Its Involvement In Rectal Cancer
52. Effects Of Interval Between Neoadjuvant Chemoradiation Therapy And Radical Surgery On Short And Long Term Outcome For Local Advanced Rectal Cancer
53. Identifying Differentially Expressed Genes And Predictive Biomarkers Of Neoadjuvant Chemoradiotherapy In Rectal Carcinoma
54. The Value Of Endorectal Ultrasound In Evaluating The Efficacy Of Neoadjuvant Chemoradiotherapy For Advanced Rectal Cancer
55. MRI And Radiomics Values In Predicting Treatment Response And Outcomes Of Rectal Cancer Patients Treated By Neoadjuvant Chemoradiotherapy
56. Effect Of Cholesterol On Neoadj Uvant Therapy For Colorectal Cancer And The Mechanism Of MiR-33a-PIM Kinase Pathway
57. Study On The Relationship Between MSI And KRAS Gene Mutations In Colorectal Cancer And The Effect Of Neoadjuvant Therapy On Tumor Immune Microenvironment
58. PART Ⅰ:staging Optimization For Rectal Cancer After Neoadjuvant Therapy PART Ⅱ:prediction For Lymph Node Metastasis In Rectal Cancer Based On Transcriptomics
59. The Association Between Neoadjuvant Chemoradiotherapy And Gut Microbes And Systemic Immunoinflammatory Markers In Rectal Cancer
60. A Series Of Studies On Neoadjuvant Chemoradiotherapy Combined With Surgery For Localle Advanced Esophageal Squamous Cell Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to